![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 31/506 | (2013.01) | ||
A61K 31/4706 | (2006.01) | ||
A61K 31/517 | (2013.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/4706 | (2013.01) | ||
A61K 31/517 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/00 | (2006.01) |
(11) | Patento numeris | 3454898 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17725014.9 |
Europos patento paraiškos padavimo data | 2017-05-09 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/031771 |
Data | 2017-05-09 |
(87) | Numeris | WO 2017/196854 |
Data | 2017-11-16 |
(30) | Numeris | Data | Šalis |
201662334102 P | 2016-05-10 | US |
(72) |
SELVARAJ, Anand , US
SMITH, Peter , US
|
(73) |
Eisai R&D Management Co., Ltd. ,
6-10, Koishikawa 4-chome
Bunkyo-ku, Tokyo 112-8088,
JP
|
(54) | DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION |
DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION |